Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01742169 · ClinicalTrials.gov registry record · NA
Improving Rates of Colorectal Cancer Screening Among Never Screened Patients
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 420
- Enrollment target
NCT01742169 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 420 participants.
The verdict
NCT01742169, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
Study Summary
The United States Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening using fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy, beginning at age 50 and continuing until age 75. Despite this recommendation, rates of CRC screening remain inadequate and large disparities exist. Screening rates are lower among Black and Hispanic populations, in areas with high poverty rates, among individuals with low education, and for those who utilize Medicaid or lack health insurance. This study will determine the effectiveness of a multifaceted intervention to increase the number of patients who have never been screened for CRC and are cared for at a community health center (CHC) that complete a fecal immunochemical test (FIT) within 6 months of randomization to an intervention group compared to patients in a usual care group. We believe that the proposed intervention will improve the CRC screening rate in a cost-effective and sustainable way, ultimately leading to a reduction in the high rate of CRC. Aim 1: To conduct a randomized controlled trial to determine if a multifaceted intervention increases the proportion of patients who complete a FOBT within 6-months of randomization. Hypothesis 1: Compared to usual care, the intervention will increase the proportion of never-screened patients who complete FOBT within 6 months of randomization. Aim 2: Assess the costs of the intervention and the costs per additional initial screening compared to patients who receive usual care.
Interventions
- BEHAVIORAL Outreach and Reminder Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01742169
The ClinicalTrials.gov registry entry for NCT01742169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Outreach and Reminder Intervention is the first listed.
NCT01742169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01742169 about?
NCT01742169 is a clinical study titled "Improving Rates of Colorectal Cancer Screening Among Never Screened Patients". The United States Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening using fecal occult blood test (FOBT), sigmoidoscopy, or colonoscopy, beginning at age 50 and continuing until age 75. Despite this recommendation, rates of CRC screening remain inadequate and large...
What is the current status of trial NCT01742169?
This trial is currently completed. It is a NA study. The enrollment target is 420 participants. The study started on 2013-01. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01742169?
The interventions under investigation include: Outreach and Reminder Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01742169?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.